Vivek Kak

784 citations
42 papers · 441 indexed · h-index 11

Impact in

Papers in

    • Antimicrobial Resistance in Staphylococcus 6
    • COVID-19 Clinical Research Studies 3
    • Antifungal resistance and susceptibility 3
    • Bacterial Identification and Susceptibility Testing 3

Vivek Kak

37 papers receiving 417 citations

Peers

Vivek Kak
Comparison fields: 5 of 102
  • Molecular Medicine 40
  • Infectious Diseases 143
  • Applied Microbiology and Biotechnology 13
  • Clinical Biochemistry 38
  • Modeling and Simulation 19
Replace David E. Dassey with:
David E. Dassey United States
Eliahu Bishburg United States
Anna Biancardi Italy
Amin A. Aqel Jordan
Yu. V. Lobzin Russia
Elizabeth Prentice United States
Louise Rossignol France
Curi Kim United States
Giorgio Graziano Italy
Vivek Kak relative to David E. Dassey United States David E. Dassey's profile →
Citations per field
00.5×8.5×
David E. Dassey · 1×
Citations per year

Countries citing papers authored by Vivek Kak

Since Specialization
Citations

This map shows the geographic impact of Vivek Kak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivek Kak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivek Kak more than expected).

Fields of papers citing papers by Vivek Kak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivek Kak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivek Kak. The network helps show where Vivek Kak may publish in the future.

Co-authors

The 25 scholars most cited alongside Vivek Kak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Vivek Kak Line = papers co-authored together Vivek Kak links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20231
3 20230
4 20237
5 20223
6 20221
7 20224
8 20201
9 20201
10 20203
11 20205
12 201565
13 201516
14 201216
15 20118
16 200743
17 200524
18 200246
19 200010
20 20006

About Vivek Kak

Vivek Kak is a scholar working on Infectious Diseases, Clinical Biochemistry, Endocrinology, Virology and Neurology, having authored 42 papers that have together received 441 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (6 papers), Fungal Infections and Studies (4 papers), COVID-19 Clinical Research Studies (3 papers), Streptococcal Infections and Treatments (3 papers), Antifungal resistance and susceptibility (3 papers), Bacterial Identification and Susceptibility Testing (3 papers), Infective Endocarditis Diagnosis and Management (3 papers) and Long-Term Effects of COVID-19 (3 papers). The work is most often cited by research in Molecular Medicine (40 citations), Infectious Diseases (143 citations), Applied Microbiology and Biotechnology (13 citations), Clinical Biochemistry (38 citations) and Modeling and Simulation (19 citations). Vivek Kak has collaborated with scholars based in United States, Japan and Grenada. Frequent co-authors include Pranatharthi Chandrasekar, Kimberly R. McBride, Shipra Singh, Daniel Havlichek, Joseph W. Chow, Kerin L. Tyrrell, Diane M. Citron, Ellie J. C. Goldstein, Mala Kamboj and Gary E. Stein. Their work appears in journals such as min - Minimally Invasive Neurosurgery, The American Journal of Gastroenterology, Infectious Disease Clinics of North America, Antimicrobial Agents and Chemotherapy and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026